Overview

Prospective Feasibility Pilot Study Evaluating the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC) at Diagnosis and Disease Progression

Status:
NOT_YET_RECRUITING
Trial end date:
2029-09-15
Target enrollment:
Participant gender:
Summary
\[68Ga\]Ga-PentixaFor PET-CT will be performed in patients with Small cell lung cancer (SCLC) to confirm the targeting of CXCR4 by \[68Ga\]Ga-PentixaFor
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Institut Cancerologie de l'Ouest